Min Luo
Impact in
- Hematology top 1%
- Acute Myeloid Leukemia Research
- Hematopoietic Stem Cell Transplantation
- Cancer Research top 2%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
Papers in
-
- Epigenetics and DNA Methylation 10
- Circular RNAs in diseases 5
- CRISPR and Genetic Engineering 4
- RNA modifications and cancer 4
-
- Cancer-related molecular mechanisms research 9
- MicroRNA in disease regulation 9
- Co-authors
- Margaret A. Goodell (12 shared papers)Mira Jeong (10 shared papers)Gretchen J. Darlington (4 shared papers)Wei Li (7 shared papers)Alexander Meissner (3 shared papers)Hongcang Gu (2 shared papers)Christoph Bock (2 shared papers)Grant A. Challen (5 shared papers)
- Journals
- Blood (6 papers)Cell stem cell (3 papers)Postharvest Biology and Technology (2 papers)Molecular Therapy — Methods & Clinical Development (2 papers)Biomedicine & Pharmacotherapy (2 papers)
- Partner nations
- ChinaUnited StatesUnited Kingdom
In The Last Decade
Min Luo
52 papers receiving 3.3k citations
Min Luo's Hit Papers
Peers
Comparison fields: 5 of 113
- Hematology 950
- Cancer Research 778
- Aging 71
- Genetics 315
- Molecular Biology 2.2k
Countries citing papers authored by Min Luo
This map shows the geographic impact of Min Luo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Min Luo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Min Luo more than expected).
Fields of papers citing papers by Min Luo
This network shows the impact of papers produced by Min Luo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Min Luo. The network helps show where Min Luo may publish in the future.
Co-authors
The 25 scholars most cited alongside Min Luo, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 56 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Dnmt3a is essential for hematopoietic stem cell differentiation Hit paper breakdown → | 2011 | 797 |
| 2 | Epigenomic Profiling of Young and Aged HSCs Reveals Concerted Changes during Aging that Reinforce Self-Renewal Hit paper breakdown → | 2014 | 493 |
| 3 | 2014 | 261 | |
| 4 | 2014 | 167 | |
| 5 | 2015 | 126 | |
| 6 | 2018 | 108 | |
| 7 | 2016 | 95 | |
| 8 | 2013 | 94 | |
| 9 | 2012 | 92 | |
| 10 | c-Myc-activated long non-coding RNA H19 downregulates miR-107 and promotes cell cycle progression of non-small cell lung cancer. | 2015 | 90 |
| 11 | 2020 | 85 | |
| 12 | 2013 | 79 | |
| 13 | 2012 | 73 | |
| 14 | 2013 | 73 | |
| 15 | 2015 | 55 | |
| 16 | 2022 | 54 | |
| 17 | 2019 | 50 | |
| 18 | 2010 | 47 | |
| 19 | 2016 | 44 | |
| 20 | 2012 | 44 |
About Min Luo
Min Luo is a scholar working on Molecular Biology, Cancer Research, Hematology, Oncology and Plant Science, having authored 56 papers that have together received 3.3k indexed citations. Recurring topics across this work include Epigenetics and DNA Methylation (10 papers), Cancer-related molecular mechanisms research (9 papers), MicroRNA in disease regulation (9 papers), Acute Myeloid Leukemia Research (6 papers), Circular RNAs in diseases (5 papers), Acute Lymphoblastic Leukemia research (4 papers), CRISPR and Genetic Engineering (4 papers) and RNA modifications and cancer (4 papers). The work is most often cited by research in Hematology (950 citations), Cancer Research (778 citations), Aging (71 citations), Genetics (315 citations) and Molecular Biology (2.2k citations). Min Luo has collaborated with scholars based in China, United States and United Kingdom. Frequent co-authors include Margaret A. Goodell, Mira Jeong, Gretchen J. Darlington, Wei Li, Alexander Meissner, Hongcang Gu, Christoph Bock, Grant A. Challen, Blanca Rodríguez and Deqiang Sun. Their work appears in journals such as Blood, Cell stem cell, Postharvest Biology and Technology, Molecular Therapy — Methods & Clinical Development and Biomedicine & Pharmacotherapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.